| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |